Financials.
Financial results and investor presentations published by Aptus Pharma.
Explore documents
Investor relations
Aptus Pharma Limited
Financial results.
Financial results, first half 2026–27
2026-27 ·
Original document
Financial results, first half 2025–26
2025-26 ·
Original document
Outcome of board meeting
Financial results FY 2025-2026 and Balance Sheet as on 31 Mar 2026
Unaudited financial results for half year ended on 30 September 2025
H1FY26 Total Revenue of Rs. 1437.75 Lakhs; Up 47.38% YoY
Outcome of the Board Meeting held on November 10, 2025
Financial Results
Explore further
Continue exploring Aptus.
Explore the board or contact Aptus Pharma about investor matters.